PE investor group completes sale of clinical trial data firm Clario to Thermo Fisher for $8.9bn

The sellers were an investor group led by Astorg, Nordic Capital, Novo Holdings and Cinven.

25 March 2026•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.